Search

Your search keyword '"Brucella melitensis pathogenicity"' showing total 188 results

Search Constraints

Start Over You searched for: Descriptor "Brucella melitensis pathogenicity" Remove constraint Descriptor: "Brucella melitensis pathogenicity"
188 results on '"Brucella melitensis pathogenicity"'

Search Results

1. The arginine/ornithine binding protein ArgT plays an essential role in Brucella neotomae / Brucella melitensis to prevent intracellular killing and contribute to chronic persistence in the host.

2. A novel Brucella T4SS effector RS15060 acts on bacterial morphology, lipopolysaccharide core synthesis and host proinflammatory responses, which is beneficial for Brucella melitensis virulence.

3. Transcriptome analysis of infected human macrophages between strains of Brucella melitensis and an omp31 mutant.

4. Genome-wide analysis of Brucella melitensis growth in spleen of infected mice allows rational selection of new vaccine candidates.

5. Brucella melitensis Rev1Δwzm: Placental pathogenesis studies and safety in pregnant ewes.

6. MyD88-Dependent Glucose Restriction and Itaconate Production Control Brucella Infection.

7. Comparison of transcriptional change of B. melitensis M5-90 after macrophage infection highlights the role of ribosome gene L31 in virulence.

8. Genomic Analysis of Natural Rough Brucella melitensis Rev.1 Vaccine Strains: Identification and Characterization of Mutations in Key Genes Associated with Bacterial LPS Biosynthesis and Virulence.

9. The UTP-glucose-1-phosphate uridylyltransferase of Brucella melitensis inhibits the activation of NF-κB via regulating the bacterial type IV secretion system.

10. Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing Brucella Immunodominant Proteins in Mice and Guinea Pigs.

11. The Twin-Arginine Translocation System Is Important for Stress Resistance and Virulence of Brucella melitensis.

12. Proteomic analysis of Brucella melitensis and Brucella ovis for identification of virulence factor using bioinformatics approachs.

13. Intratracheal Inoculation with Brucella melitensis in the Pregnant Guinea Pig Is an Improved Model for Reproductive Pathogenesis and Vaccine Studies.

14. The Acidic Stress Response of the Intracellular Pathogen Brucella melitensis : New Insights from a Comparative, Genome-Wide Transcriptome Analysis.

15. Insights into irr and rirA gene regulation on the virulence of Brucella melitensis M5-90.

16. Brucella melitensis omp 31 Mutant Is Attenuated and Confers Protection Against Virulent Brucella melitensis Challenge in BALB/c Mice.

18. Comparative structure, dynamics and evolution of acyl-carrier proteins from Borrelia burgdorferi, Brucella melitensis and Rickettsia prowazekii.

19. Transcriptomic analysis of smooth versus rough Brucella melitensis Rev.1 vaccine strains reveals insights into virulence attenuation.

20. Associated factors in distinguishing patients with brucellosis from suspected cases.

21. Cellulitis in human brucellosis: An atypical presentation.

22. Modelling the immunopathophysiology of Brucella melitensis and its lipopolysaccharide in mice infected via oral route of exposure.

23. HMGB1 release from trophoblasts contributes to inflammation during Brucella melitensis infection.

24. Establishment and Initial Testing of a Medium-Sized, Surgically Feasible Animal Model for Brucellar Spondylodiscitis: A Preliminary Study.

25. A case report on mother-to-child transmission of Brucella in human, China.

26. Infection by Brucella melitensis or Brucella papionis modifies essential physiological functions of human trophoblasts.

27. A small non-coding RNA facilitates Brucella melitensis intracellular survival by regulating the expression of virulence factor.

28. Substantial Virulence Genes among Brucella melitensis Field Strains Isolated from Cattle in Egypt.

29. Predominance of Brucella abortus antibodies among women with spontaneous abortion in the city of Mwanza: unrecognized link or coincidence?

30. Antimicrobial susceptibility profile, Adherence and invasion to mammalian cells of Brucellamelitensis isolates.

31. Direct diagnosis of Brucella species through multiplex PCR formed by a new method.

32. A novel small RNA Bmsr1 enhances virulence in Brucella melitensis M28.

33. Activation of Host IRE1α-Dependent Signaling Axis Contributes the Intracellular Parasitism of Brucella melitensis .

34. Acute liver failure complication of brucellosis infection: a case report and review of the literature.

35. Comparative experimental study of Brucella melitensis and its lipopolysaccharide in mouse model infected via subcutaneous route of exposure.

36. The epidemiology of Brucellosis in Greece, 2007-2012: a 'One Health' approach.

37. Pigs, pooches and pasteurisation: The changing face of brucellosis in Australia

38. 3D correlative electron microscopy reveals continuity of Brucella -containing vacuoles with the endoplasmic reticulum.

39. Genomic analysis of the original Elberg Brucella melitensis Rev.1 vaccine strain reveals insights into virulence attenuation.

40. Oral immunization of mice with Omp31-loaded N -trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection.

41. Sociospatial structure explains marked variation in brucellosis seroprevalence in an Alpine ibex population.

42. Human Brucella melitensis infections in southern Vietnam.

43. Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen.

44. Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1.

45. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.

46. Omp31 plays an important role on outer membrane properties and intracellular survival of Brucella melitensis in murine macrophages and HeLa cells.

47. Comparative study of immunopathophysiological responses induced by B. melitensis and its lipopolysaccharide in mouse model infected via intranasal route of exposure.

48. Brucella melitensis M5-90Δbp26 as a potential live vaccine that allows for the distinction between natural infection and immunization.

49. Evaluation of plasma sphingosine 1-phosphate, hepcidin and cardiovascular damage biomarkers (cardiac troponin I and homocysteine) in rats infected with brucellosis and vaccinated (Rev-1, RB-51).

50. Molecular investigation of virulence factors of Brucella melitensis and Brucella abortus strains isolated from clinical and non-clinical samples.

Catalog

Books, media, physical & digital resources